Skip to Main Content

Login to your account

Show
Forgot password?
Don’t have an account?
Create a Free Account

If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password

If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password

Cancel
ADVERTISEMENT
SCROLL TO CONTINUE WITH CONTENT



Property Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes
Advertisement
RBMO
  • Submit
  • Log in
  • Register
  • Log in
    • Submit
    • Log in
  • Subscribe
  • Claim
Skip menu
  • Articles
    • Cover Image - Reproductive BioMedicine Online, Volume 46, Issue 3
    • Latest

      • Articles in Press
      • Current Issue
      • Past Issues
      • Editor's Choice
  • Publish
    • For Authors

      • Submit Article
        External Link
      • Guide for Authors
      • Aims & Scope
      • Open Access Information
        External Link
      • Researcher Academy
        External Link
  • Topics
      • Hot Topics
      • First RBM Online Session at COGI
        External Link
      • Bob Edwards Nobel Laureate Collection
      • Ethics Bioscience and Life
      • Meeting Abstracts
      • Robert G. Edwards Prize Paper Award
        External Link
      • Robert G. Edwards Prize Paper Award Winners
  • About
    • Society

      • Affiliated Societies
      • Editorial Board
      • Events
      • RBMO DIGEST
    • Journal Information

      • Aims & Scope
      • Permissions
      • Reprints
        External Link
      • Abstracting & Indexing
      • Editor Declarations of Interest
      • Institutional and Other
        External Link
    • Access

      • Subscribe
      • Activate Online Access
  • Contact
    • Contact

      • Contact Us
      • Career Opportunities
        External Link
      • Advertise with Us
        External Link
      • Go to Product Catalog
        External Link
    • Follow Us

      • New Content Alerts
Advanced search
Advanced search

Please enter a term before submitting your search.

Ok
x

Filter:

Filters applied

  • Editor
  • IVFRemove IVF filter
Clear all

Article Type

  • Research Article20
  • Review Article2

Publication Date

  • Last 6 Months1
  • Last Year4
  • Last 2 Years5
  • Last 5 Years9
Please choose a date range between 2011 and 2022.

Author

  • Humaidan, Peter3
  • Daneshmand, Said T2
  • Garner, Forest C2
  • Aguirre, Martha1
  • Alsbjerg, Birgit1
  • Alves, Elisabete1
  • Alvino, Helen1
  • Andersen, Claus Yding1
  • Arts, JGEM1
  • Athanasiou, Pantelitsa1
  • Bardet, Léna1
  • Beeson, Diane1
  • Benadiva, Claudio1
  • Bentov, Yaakov1
  • Bisotto, Sandra1
  • Bissonnette, François1
  • Bourdiec, Amélie1
  • Burgerhof, JGM1
  • Buzaglo, Karen1
  • Casper, Robert F1
  • Cecchino, GN1
  • Cerrillo, M1
  • Chang, Paul1
  • Chen, Chuangqi1
  • Consensus Group, Cairo1

Journal

  • Reproductive BioMedicine Online22

Keyword

  • ICSI2
  • ovarian stimulation2
  • PGT-A2
  • Poor responders2
  • Add-ons1
  • ART1
  • Assisted hatching1
  • Assisted reproductive technology1
  • Autologous endometrial co-culture1
  • Biopsy1
  • Conservative management1
  • Corpus luteum1
  • Culture conditions1
  • Cumulative live birth rate1
  • DuoStim1
  • Endometrial atypical hyperplasia1
  • Endometrial cancer1
  • Estradiol1
  • Euploid blastocyst1
  • Evidence-based medicine1
  • Exclusion criteria1
  • Fertility preservation1
  • GnRH agonist1
  • GnRH agonist trigger1

Access Filter

  • Open Access

Editor's Choice

22 Results
Subscribe to collection
  • Export
    • PDF
    • Citation

Please select at least one article in order to proceed.

Ok
FilterHide Filter
  • Article

    A randomized, non-inferiority trial on the DuoStim strategy in PGT-A cycles

    Reproductive BioMedicine Online
    Vol. 46Issue 3p536–542Published online: November 24, 2022
    • M. Cerrillo
    • G.N. Cecchino
    • M. Toribio
    • M.J. García-Rubio
    • J.A. García-Velasco
    Cited in Scopus: 0
    • Preview Hide Preview
    • Download PDF
    • Export Citation
      Is the DuoStim strategy an effective alternative to two conventional ovarian stimulation cycles in poor-prognosis patients undergoing preimplantation genetic testing for aneuploidies (PGT-A) to improve euploidy rates and obtain the first euploid embryo in less time?
      A randomized, non-inferiority trial on the DuoStim strategy in PGT-A cycles
    • Article
      Open Access

      Preimplantation genetic testing for human blastocysts with potential parental contamination using a quantitative parental contamination test (qPCT): an evidence-based study

      Reproductive BioMedicine Online
      Vol. 46Issue 1p69–79Published online: August 21, 2022
      • Yunqiao Dong
      • Dun Liu
      • Yangyun Zou
      • Cheng Wan
      • Chuangqi Chen
      • Mei Dong
      • and others
      Cited in Scopus: 1
      • Preview Hide Preview
      • Download PDF
      • Export Citation
        Is it possible to develop a quantitative method for detecting parental DNA contamination in conventional IVF using preimplantation genetic testing for aneuploidy (PGT-A)?
        Preimplantation genetic testing for human blastocysts with potential parental contamination using a quantitative parental contamination test (qPCT): an evidence-based study
      • Article

        Does the HCG trigger dose used for IVF impact luteal progesterone concentrations? a randomized controlled trial

        Reproductive BioMedicine Online
        Vol. 45Issue 4p793–804Published online: May 5, 2022
        • Louise Svenstrup
        • Sören Möller
        • Jens Fedder
        • Dorrit Elschner Pedersen
        • Karin Erb
        • Claus Yding Andersen
        • and others
        Cited in Scopus: 0
        • Preview Hide Preview
        • Download PDF
        • Export Citation
          Is there an association between the ovulation trigger dose of human chorionic gonadotrophin (HCG) and endogenous progesterone production during the luteal phase?
          Does the HCG trigger dose used for IVF impact luteal progesterone concentrations? a randomized controlled trial
        • Article

          Comparison of predictive models for cumulative live birth rate after treatment with ART

          Reproductive BioMedicine Online
          Vol. 45Issue 2p246–255Published online: March 31, 2022
          • Léna Bardet
          • Jean-Baptiste Excoffier
          • Noemie Salaun-Penquer
          • Matthieu Ortala
          • Maud Pasquier
          • Emmanuelle Mathieu d'Argent
          • and others
          Cited in Scopus: 0
          • Preview Hide Preview
          • Download PDF
          • Export Citation
            Can a machine learning model better predict the cumulative live birth rate for a couple after intrauterine insemination or embryo transfer than Cox regression based on their personal characteristics?
            Comparison of predictive models for cumulative live birth rate after treatment with ART
          • Article

            IVF impact on the risk of recurrence of endometrial adenocarcinoma after fertility-sparing management

            Reproductive BioMedicine Online
            Vol. 43Issue 3p495–502Published online: June 16, 2021
            • Maïlys Vaugon
            • Maëliss Peigné
            • Juliette Phelippeau
            • Clémentine Gonthier
            • Martin Koskas
            Cited in Scopus: 5
            • Preview Hide Preview
            • Download PDF
            • Export Citation
              Do IVF treatments after conservative management of endometrial atypical hyperplasia or grade 1 endometrial adenocarcinoma (AH/EC) increase the risk of disease recurrence?
              IVF impact on the risk of recurrence of endometrial adenocarcinoma after fertility-sparing management
            • Article
              Open Access

              The prevalence, promotion and pricing of three IVF add-ons on fertility clinic websites

              Reproductive BioMedicine Online
              Vol. 41Issue 5p801–806Published online: July 27, 2020
              • Lucy van de Wiel
              • Jack Wilkinson
              • Pantelitsa Athanasiou
              • Joyce Harper
              Cited in Scopus: 17
              • Preview Hide Preview
              • Download PDF
              • Export Citation
                How are IVF clinic websites advertising three common IVF add-ons: assisted hatching, time-lapse embryo imaging and preimplantation genetic testing for aneuploidies (PGT-A)?
                The prevalence, promotion and pricing of three IVF add-ons on fertility clinic websites
              • Article
                Open Access

                ‘There is only one thing that is truly important in an IVF laboratory: everything’ Cairo Consensus Guidelines on IVF Culture Conditions

                Reproductive BioMedicine Online
                Vol. 40Issue 1p33–60Published online: October 10, 2019
                • Cairo Consensus Group
                Cited in Scopus: 24
                • Preview Hide Preview
                • Download PDF
                • Export Citation
                  This proceedings report presents the outcomes from an international expert meeting to establish consensus guidelines on IVF culture conditions. Topics reviewed and discussed were: embryo culture – basic principles and interactions; temperature in the IVF laboratory; humidity in culture; carbon dioxide control and medium pH; oxygen tension for embryo culture; workstations – design and engineering; incubators – maintaining the culture environment; micromanipulation – maintaining a steady physcochemical environment; handling practices; assessment practices; culture media – buffering and pH, general composition and protein supplementation, sequential or single-step media for human embryo culture; use and management – cold chain and storage; test equipment – calibration and certification; and laboratory equipment and real-time monitoring.
                • Article

                  Human growth hormone for poor responders: a randomized placebo-controlled trial provides no evidence for improved live birth rate

                  Reproductive BioMedicine Online
                  Vol. 38Issue 6p908–915Published online: February 26, 2019
                  • Robert J. Norman
                  • Helen Alvino
                  • Louise M. Hull
                  • Ben W. Mol
                  • Roger J. Hart
                  • Thu-Lan Kelly
                  • and others
                  Cited in Scopus: 36
                  • Preview Hide Preview
                  • Download PDF
                  • Export Citation
                    Does the addition of human growth hormone (HGH) to an IVF cycle improve the live birth rate in previously documented poor responders to FSH?
                    Human growth hormone for poor responders: a randomized placebo-controlled trial provides no evidence for improved live birth rate
                  • Article

                    Autologous endometrial cell co-culture improves human embryo development to high-quality blastocysts: a randomized controlled trial

                    Reproductive BioMedicine Online
                    Vol. 38Issue 3p321–329Published online: January 5, 2019
                    • Cécile Le Saint
                    • Kimberley Crespo
                    • Amélie Bourdiec
                    • François Bissonnette
                    • Karen Buzaglo
                    • Bernard Couturier
                    • and others
                    Cited in Scopus: 6
                    • Preview Hide Preview
                    • Download PDF
                    • Export Citation
                      Does autologous endometrial cell co-culture (AECC) improve the number of good-quality blastocysts obtained by IVF/intracytoplasmic sperm injection (ICSI), compared with conventional embryo culture medium in a broad group of patients referred to assisted reproductive technology (ART)?
                      Autologous endometrial cell co-culture improves human embryo development to high-quality blastocysts: a randomized controlled trial
                    • Review

                      Insights from clinical experience in treating IVF poor responders

                      Reproductive BioMedicine Online
                      Vol. 36Issue 1p12–19Published online: October 25, 2017
                      • Kelly J. Gonda
                      • Alice D. Domar
                      • Norbert Gleicher
                      • Richard P. Marrs
                      Cited in Scopus: 25
                      • Preview Hide Preview
                      • Download PDF
                      • Export Citation
                        ‘Poor responders’ is a term used to describe a subpopulation of IVF patients who do not respond well to ovarian stimulation with gonadotrophins. While there is no standard definition of a poor responder, these patients tend to be of advanced maternal age (≥40 years), have a history of poor ovarian response with conventional stimulation protocols, and/or have low ovarian reserve. Despite the heterogeneity of this patient group, there are characteristics and needs common to many poor responders that can be addressed through a holistic approach.
                        Insights from clinical experience in treating IVF poor responders
                      • Article

                        Bio-equivalent doses of recombinant HCG and recombinant LH during ovarian stimulation result in similar oestradiol output: a randomized controlled study

                        Reproductive BioMedicine Online
                        Vol. 35Issue 2p232–238Published online: May 11, 2017
                        • Birgit Alsbjerg
                        • Helle Olesen Elbaek
                        • Rita Jakubcionyte Laursen
                        • Betina Boel Povlsen
                        • Thor Haahr
                        • Claus Yding Andersen
                        • and others
                        Cited in Scopus: 0
                        • Preview Hide Preview
                        • Download PDF
                        • Export Citation
                          In nature, HCG is secreted by the implanting embryo from peri-implantation and onwards. In contrast, LH is mandatory for steroidogenesis and follicular development during the follicular phase, working in synergy with FSH. Moreover, LH is mandatory for the function of the corpus luteum. Although LH and HCG bind to the same receptor, significant molecular, structural and functional differences exist, inducing differences in bioactivity. This randomized controlled study compared the effect of recombinant FSH stimulation combined with daily either micro-dose recombinant HCG or recombinant LH supplementation in a 1:1 bioactivity ratio from day 1 of stimulation in a long gonadotrophin releasing hormone agonist down regulation protocol.
                          Bio-equivalent doses of recombinant HCG and recombinant LH during ovarian stimulation result in similar oestradiol output: a randomized controlled study
                        • Article

                          ‘Model’ versus ‘everyday’ patients: can randomized controlled trial data really be applied to the clinic?

                          Reproductive BioMedicine Online
                          Vol. 34Issue 3p274–279Published online: December 15, 2016
                          • Eliyakim Hershkop
                          • Linoy Segal
                          • Ofer Fainaru
                          • Shahar Kol
                          Cited in Scopus: 20
                          • Preview Hide Preview
                          • Download PDF
                          • Export Citation
                            New drug approval requires a new drug to undergo rigorous clinical trials to determine its efficacy and safety. A drug is approved only for the population on which it was tested, i.e. those who meet the inclusion criteria of the trial. The aim of this study was to determine what percentage of ‘real life’ patients in our clinic meet the inclusion and exclusion criteria used in large-scale clinical trials required for drug registration in the field of assisted reproduction. All 265 consecutive patients with pertinent data treated in a tertiary centre IVF Unit during 2015 were surveyed.
                          • Review

                            GnRH agonist trigger for the induction of oocyte maturation in GnRH antagonist IVF cycles: a SWOT analysis

                            Reproductive BioMedicine Online
                            Vol. 32Issue 3p274–285Published online: January 5, 2016
                            • Lawrence Engmann
                            • Claudio Benadiva
                            • Peter Humaidan
                            Cited in Scopus: 71
                            • Preview Hide Preview
                            • Download PDF
                            • Export Citation
                              Gonadotrophin releasing hormone agonist (GnRHa) trigger is effective in the induction of oocyte maturation and prevention of ovarian hyperstimulation syndrome during IVF treatment. This trigger concept, however, results in early corpora lutea demise and consequently luteal phase dysfunction and impaired endometrial receptivity. The aim of this strenghths, weaknesses, opportunities and threats analysis was to summarize the progress made over the past 15 years to optimize ongoing pregnancy rates after GnRHa trigger.
                            • Article

                              Factors associated with willingness to donate embryos for research among couples undergoing IVF

                              Reproductive BioMedicine Online
                              Vol. 32Issue 2p247–256Published online: November 30, 2015
                              • Catarina Samorinha
                              • Milton Severo
                              • Elisabete Alves
                              • Helena Machado
                              • Bárbara Figueiredo
                              • Susana Silva
                              Cited in Scopus: 10
                              • Preview Hide Preview
                              • Download PDF
                              • Export Citation
                                Most couples enrolled in IVF and intracytoplasmic sperm injection (ICSI) cycles need to make decisions about embryo disposition (Provoost et al., 2010; Wånggren et al., 2013). It has been consistently shown that this is a complex decision-making process, involving different sequential stages that can change over time (de Lacey, 2005; Provoost et al., 2009, 2012a). Patients undergoing IVF usually reveal multifaceted views about embryo status (Haimes and Taylor, 2009; Provoost et al., 2009), disagreements between partners (Provoost et al., 2012b) and emotional distress (de Lacey, 2005; Fuscaldo et al., 2007).
                              • Article

                                A pilot study to evaluate a device for the intravaginal culture of embryos

                                Reproductive BioMedicine Online
                                Vol. 31Issue 6p732–738Published online: September 17, 2015
                                • Frederic Mitri
                                • Navid Esfandiari
                                • Joan Coogan-Prewer
                                • Paul Chang
                                • Yaakov Bentov
                                • John McNaught
                                • and others
                                Cited in Scopus: 6
                                • Preview Hide Preview
                                • Download PDF
                                • Export Citation
                                  The aim of this comparative randomized embryology trial was to determine if an intravaginal culture device (IVC) can provide acceptable embryo development compared with conventional IVF. Ten women between the ages of 27 and 37 years with an indication for IVF treatment were included in this study. After ovarian stimulation, oocytes were randomized to fertilization in the IVC device or using conventional IVF. Fertilization rates were higher in the IVF group compared with the IVC device (68.7% ± 36 % versus 40.7% ± 27%), respectively, whereas cleavage rates were similar (93% ± 1.5% versus 97% ± 6%) for both groups.
                                  A pilot study to evaluate a device for the intravaginal culture of embryos
                                • Article

                                  What's in a name? Variations in terminology of third-party reproduction

                                  Reproductive BioMedicine Online
                                  Vol. 31Issue 6p805–814Published online: September 15, 2015
                                  • Diane Beeson
                                  • Marcy Darnovsky
                                  • Abby Lippman
                                  Cited in Scopus: 20
                                  • Preview Hide Preview
                                  • Download PDF
                                  • Export Citation
                                    The terminology used to discuss third-party reproduction, as with other new biomedical processes, can ease or impede communication and even influence behaviour. In an effort to sensitize analysts and stakeholders to variations in terminology and to facilitate communication on issues arising from international surrogacy arrangements, this paper examines variations in terms used. We introduce some of the issues previously raised by scholars concerned with analysis of discourse related to third-party reproduction.
                                  • Article

                                    Freeze-all can be a superior therapy to another fresh cycle in patients with prior fresh blastocyst implantation failure

                                    Reproductive BioMedicine Online
                                    Vol. 29Issue 3p286–290Published online: May 14, 2014
                                    • Bruce S Shapiro
                                    • Said T Daneshmand
                                    • Forest C Garner
                                    • Martha Aguirre
                                    • Cynthia Hudson
                                    Cited in Scopus: 52
                                    • Preview Hide Preview
                                    • Download PDF
                                    • Export Citation
                                      Despite numerous advances in assisted reproduction, implantation failure remained the most common outcome following embryo transfer in 2011 (Society for Assisted Reproductive Technology, 2011). Most fresh autologous embryo transfers in 2011 failed to result in live birth, and national average implantation rates ranged from 4–36%, depending on maternal age. Therefore, a large proportion of patients undergoing IVF experience at least one fresh embryo transfer cycle resulting in implantation failure.
                                      Freeze-all can be a superior therapy to another fresh cycle in patients with prior fresh blastocyst implantation failure
                                    • Article

                                      Outcomes of blastocysts biopsied and vitrified once versus those cryopreserved twice for euploid blastocyst transfer

                                      Reproductive BioMedicine Online
                                      Vol. 29Issue 1p59–64Published online: March 17, 2014
                                      • Tyl H. Taylor
                                      • Jennifer L. Patrick
                                      • Susan A. Gitlin
                                      • J. Michael Wilson
                                      • Jack L. Crain
                                      • Darren K. Griffin
                                      Cited in Scopus: 35
                                      • Preview Hide Preview
                                      • Download PDF
                                      • Export Citation
                                        Trophectoderm biopsy with comprehensive chromosome screening (CCS) has been shown to increase implantation and pregnancy rates. Some patients desire CCS on previously cryopreserved blastocysts, resulting in blastocysts that are thawed/warmed, biopsied, vitrified and then warmed again. The effect of two cryopreservation procedures and two thawing/warming procedures on outcomes has not been effectively studied. Cycles were divided into two groups: group 1 patients underwent a cryopreserved embryo transfer with euploid blastocysts that were vitrified and warmed once; group 2 patients had a cryopreserved embryo transfer of a euploid blastocyst that was cryopreserved, thawed/warmed, biopsied, vitrified and warmed.            
                                        Outcomes of blastocysts biopsied and vitrified once versus those cryopreserved twice for euploid blastocyst transfer
                                      • Article

                                        Effectiveness of indometacin to prevent ovulation in modified natural-cycle IVF: A randomized controlled trial

                                        Reproductive BioMedicine Online
                                        Vol. 27Issue 3p297–304Published online: May 23, 2013
                                        • T.M. Rijken-Zijlstra
                                        • M.L. Haadsma
                                        • C. Hammer
                                        • J.G.M. Burgerhof
                                        • M.J. Pelinck
                                        • A.H.M. Simons
                                        • and others
                                        Cited in Scopus: 17
                                        • Preview Hide Preview
                                        • Download PDF
                                        • Export Citation
                                          Modified natural-cycle IVF has a lower pregnancy rate per started cycle as compared with IVF with ovarian stimulation due to, for example, premature ovulation. Indometacin administered before ovulation prevents follicle rupture. Therefore, addition of indometacin may improve the effectiveness of modified natural-cycle IVF. This double-blind, randomized, placebo-controlled trial with indometacin or placebo in 120 women aged 27–36 years compared the number of patients without premature ovulation as compared with the number of patients with one or more ovulations in a maximum of six cycles.   
                                          Effectiveness of indometacin to prevent ovulation in modified natural-cycle IVF: A randomized controlled trial
                                        • Article

                                          IVF versus ICSI for the fertilization of in-vitro matured human oocytes

                                          Reproductive BioMedicine Online
                                          Vol. 25Issue 6p603–607Published online: September 3, 2012
                                          • M. Walls
                                          • S. Junk
                                          • J.P. Ryan
                                          • R. Hart
                                          Cited in Scopus: 44
                                          • Preview Hide Preview
                                          • Download PDF
                                          • Export Citation
                                            Traditional dogma suggests that intracytoplasmic sperm injection (ICSI) should be performed to ensure successful oocyte fertilization in an in-vitro maturation (IVM) cycle. This study postulated that there would be no difference in the fertilization rate when ICSI was compared with IVF. This hypothesis was tested in a randomized trial of IVF versus ICSI in IVM. A total of 150 immature oocytes were collected in eight cycles of IVM for patients diagnosed with polycystic ovarian syndrome (PCOS). Patients were primed with minimal FSH before transvaginal oocyte aspiration.
                                          • Article

                                            Serum HCG measured in the peri-implantation period predicts IVF cycle outcomes

                                            Reproductive BioMedicine Online
                                            Vol. 25Issue 3p248–253Published online: June 20, 2012
                                            • Bruce S. Shapiro
                                            • Said T. Daneshmand
                                            • Humberto Restrepo
                                            • Forest C. Garner
                                            Cited in Scopus: 19
                                            • Preview Hide Preview
                                            • Download PDF
                                            • Export Citation
                                              The current study assessed the relationship between serum concentrations of human chorionic gonadotrophin (HCG) measured in the peri-implantation period and various outcome measures following blastocyst transfer in IVF cycles. The study group included 767 autologous IVF cycles, each with the transfer of two fresh blastocysts in a 6-year study period, ending 31 December 2009. Outcome measures were ectopic pregnancy, biochemical pregnancy loss, ongoing pregnancy, spontaneous abortion and multiple pregnancy.  
                                              Serum HCG measured in the peri-implantation period predicts IVF cycle outcomes
                                            • Article

                                              Optimization of cryocycles by using pinopode detection in patients with multiple implantation failure: preliminary report

                                              Reproductive BioMedicine Online
                                              Vol. 22Issue 6p590–596Published online: February 14, 2011
                                              • I. Sudoma
                                              • Y. Goncharova
                                              • V. Zukin
                                              Cited in Scopus: 19
                                              • Preview Hide Preview
                                              • Download PDF
                                              • Export Citation
                                                The aim of this study was to investigate pinopode formation patterns in patients with a history of multiple IVF failures and to evaluate if their detection with subsequent modification of protocols using frozen–thawed embryos could help to increase the pregnancy and live-birth rates in these patients. The study included 55 women with at least three implantation failures. On-time pinopodes were present in only 12.7% of cases, the rest showed acceleration, delay, arrest or asynchronization of pinopode formation.
                                              Page 1 of 1
                                              • Home
                                              • Articles & Issues
                                              • Articles In Press
                                              • Current Issue
                                              • Editor's Choice
                                              • Hot Topics
                                              • List of Issues
                                              • Supplements
                                              • Collections
                                              • First RBM Online Session at COGI
                                              • Bob Edwards Nobel Laureate Collection
                                              • Ethics Bioscience and Life
                                              • Meeting Abstracts
                                              • Robert G. Edwards Prize Paper Award
                                              • Robert G. Edwards Prize Paper Award Winners
                                              • For Authors
                                              • About Open Access
                                              • Author Information
                                              • Permissions
                                              • Researcher Academy
                                              • Submit a Manuscript
                                              • Journal Info
                                              • About Open Access
                                              • About the Journal
                                              • Abstracting/Indexing
                                              • Activate Online Access
                                              • Career Opportunities
                                              • Contact Information
                                              • Editorial Board
                                              • Information for Advertisers
                                              • Pricing
                                              • New Content Alerts
                                              • Subscriptions
                                              • Institutional and Other
                                              • Personal Pricing
                                              • Events & Society Info
                                              • Affiliated Societies
                                              • Events
                                              • RBMO DIGEST

                                              The content on this site is intended for healthcare professionals.



                                              We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
                                              Copyright © 2023 Elsevier Inc. except certain content provided by third parties.

                                              • Privacy Policy  
                                              • Terms and Conditions  
                                              • Accessibility  
                                              • Help & Contact

                                              RELX